[Serological modifications of blood group antigens from human blood cells in malignant diseases. Causes, serological character and meaning].
D000017:ABO Blood-Group System; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D001789:Blood Group Antigens / Q000187:drug effects; D001792:Blood Platelets / Q000276:immunology; D004912:Erythrocytes / Q000276:immunology; D006386:Hemagglutination Tests; D006648:Histocompatibility; D006801:Humans; D007125:Immunogenetics; D007519:Isoantigens / Q000032:analysis*; D007938:Leukemia / Q000276:immunology; D007962:Leukocytes / Q000276:immunology; D009369:Neoplasms / Q000276:immunology*; D011817:Rabbits; D012204:Rh-Hr Blood-Group System; D014181:Transplantation Immunology
D000017:ABO Blood-Group System; D000970:Antineoplastic Agents; D001789:Blood Group Antigens; D007519:Isoantigens; D012204:Rh-Hr Blood-Group System
Serologische Modifikationene der Blutgruppenantigene menschlicher Blutzellen bei malignen Erkrankungen. Grundlagen, serologischer Charakter und Bedeutung.